Healthcare Royalty, Inc. Contracts & Agreements
15 Contracts & Agreements
- Business Finance (8 contracts)
- Business Formation (1)
- Business Operations (4)
- Human Resources (1)
- Mergers & Acquisitions (1)
- Agreement and Plan of Reorganization, dated June 30, 2021, by and between Healthcare Royalty Management, LLC, Healthcare Royalty, Inc., and other parties named therein (Filed With SEC on August 3, 2021)
- Form of Underwriting Agreement (Filed With SEC on July 29, 2021)
- Form of Class A Common Stock Certificate (Filed With SEC on July 29, 2021)
- Royalty Purchase Agreement, dated as of January 6, 2018, between Antigenics LLC and Healthcare Royalty Partners III, L.P., and certain affiliated funds identified therein (Filed With SEC on July 29, 2021)
- Form of 2021 Omnibus Incentive Compensation Plan for Directors (Filed With SEC on July 29, 2021)
- Form of Management and Services Agreement (Filed With SEC on July 1, 2021)
- Form of Registration Rights Agreement (Filed With SEC on July 1, 2021)
- Form of Director and Officer Indemnification Agreement (Filed With SEC on July 1, 2021)
- Form of Limited Partnership Agreement of Healthcare Royalty Holdings, L.P (Filed With SEC on July 1, 2021)
- Form of Exchange Agreement (Filed With SEC on July 1, 2021)
- Form of Legacy Management Agreement (Filed With SEC on July 1, 2021)
- Asset Purchase Agreement, dated July 7, 2020, between Harris FRC Acquisition, LP and Harris FRC Corporation (Filed With SEC on July 1, 2021)
- Purchase and Sale Agreement, dated as of February 2, 2017, by and between Portola Pharmaceuticals and Entities Managed by Healthcare Royalty Management, LLC (Filed With SEC on July 1, 2021)
- Royalty Interest Acquisition Agreement, dated as of April 22, 2016, between Aviragen Therapeutics, Inc., Biota Scientific Management Pty. Ltd. and Biota Holdings Pty Ltd. and... (Filed With SEC on July 1, 2021)
- Royalty Purchase Agreement, dated as of January 6, 2018, between Antigenics LLC and Healthcare Royalty Partners III, L.P., and certain affiliated funds identified therein (Filed With SEC on July 1, 2021)
